Verano Holdings Corp. (CNSX: VRNO)
Health Care · Pharmaceuticals · US
CA$8.55
0.00% today · -26.3% 1Y
Verano Holdings Corp. (CNSX: VRNO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $454.65M and employs 3,780 people.
Over the last twelve months the share price has lost 26.3%, trading between 5.50 and 13.30.
Tweenvest scores Verano Holdings Corp. across four factors: quality 52/100, value 59/100, growth 24/100. Its strongest factor is value.
VRNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $454.65M
- Revenue (TTM)
- $835.52M
- P/E
- —
- EPS
- -3.58
- Dividend yield
- —
- Beta (5Y)
- 1.42
- 52-week high
- CA$13.30
- 52-week low
- CA$5.50
- Avg volume (3M)
- —
- Shares outstanding
- 73.22M
- Employees
- 3,780
- Next earnings
- —
About Verano Holdings Corp.
Verano Holdings Corp. functions as a comprehensive, vertically integrated cannabis enterprise operating across numerous states in the United States. The company oversees the entire cannabis lifecycle, from cultivating and processing to wholesale distribution and direct-to-consumer retail sales, within Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It provides a variety of artisanal cannabis products through its proprietary brands, including Encore, Avexia, MUV, and Verano, serving both medical and adult-use markets. By May 10, 2022, Verano's operational footprint included 96 retail dispensaries alongside 13 facilities dedicated to cultivation and processing. The firm's corporate base is located in Chicago, Illinois.
- ISIN
- US92339H2004
- Listed since
- Feb 17, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,245.00 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.54 | -0.55% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.00 | +0.23% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.04 | +0.25% |
Figures last refreshed Sep 14, 2024.